Bristol Myers Squibb
Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Develo
Bristol Myers Squibb, Boston, Massachusetts, us, 02298
Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development
Challenging. Meaningful. Life‑changing. Those aren’t words usually associated with a job. But working at Bristol Myers Squibb is anything but ordinary. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high‑achieving teams. Take your career farther than you thought possible.
Position Summary
The Clinical Biomarker Asset Lead will be responsible for developing and executing translational strategies in solid tumor oncology for assigned programs. The role involves acting as a lead scientist to implement and deliver biomarker strategies for clinical programs, developing reports and publications on translational data to support asset development, and contributing to regulatory submissions. The individual will work on cross‑functional project teams to drive the execution of translational/biomarker plans with disease and lab scientists, and with BMS members from clinical, medical, commercial, regulatory, and diagnostics. The lead will also engage external academic collaborators and Key Opinion Leaders.
Key Responsibilities
Integrate translational research and clinical development, developing biomarker strategies in alignment with clinical objectives, leading data generation and interpretation, and communicating results to development teams.
Understand the external research environment and partner with internal and external functions to coordinate translational development deliverables.
Engage functional groups to develop, champion, and align biomarker strategies for development projects in support of the R&D portfolio goals.
Effectively engage with teams and matrix leadership to define, revise, and progress translational biomarker plans.
Analyze progress, apply critical thinking, and solve problems to deliver key data and interpretations essential for decision making.
Deliver high‑quality biomarker strategies for mechanism of action/resistance, target engagement, pharmacodynamics endpoints, and patient selection.
Ensure the output of biomarker plans meets established project standards.
Engage team members to align biomarker strategies with clinical operational plans and functional capabilities to execute a robust translational biomarker data package to support trial and program.
Build productive relationships with team members that interact with the translational clinical biomarker group.
Interface with functional areas to ensure strategic alignment and identify resources needed to deliver biomarker goals.
Engage external collaborators and scientific KOLs to support translational goals.
Communicate key biomarker program information, risks, and milestones, and manage information flow across team members.
Qualifications & Experience
Ph.D. in Oncology, immunology, or related field.
5–8+ years of industry experience, including 3–5 years in oncology, biomarkers, translational, or correlative research.
Previous experience as Biomarker Lead for late‑stage clinical trials; experience in phases II/III required.
Comprehensive knowledge of principles, concepts, and methodologies within drug discovery or clinical development.
Significant understanding of the role of translational research and clinical biomarkers in drug development.
Demonstrated knowledge of oncology and/or tumor‑immunology disease biology.
Regulatory submission experience in the solid tumor space highly desirable.
In‑depth understanding of solid tumor oncology and current evolving clinical landscape.
Strong scientific background with understanding of clinical, translational, and mechanistic data and a proven track record of publications.
Understanding of early or late‑stage drug and translational development process; experience implementing a biomarker strategy.
Clinical protocol authoring and regulatory document review.
Working knowledge of biomarker platforms including genomics, gene expression, immune profiling, and flow cytometry.
Excellent data analysis and problem‑solving skills.
Exceptional verbal and written communication skills with experience developing manuscripts, presentations, and regulatory submissions (INDs/NDAs).
Proven scientific/project leadership experience and global team collaboration.
Compensation Overview
Cambridge, MA: $214,020 – $259,344
Princeton, NJ: $186,110 – $225,519
Benefits
Health coverage: medical, pharmacy, dental, and vision care.
Well‑being support: BMS Well‑Being Account, BMS Living Life Better, and Employee Assistance Programs.
Financial well‑being and protection: 401(k), disability insurance, life insurance, accident insurance, supplemental health insurance, business travel protection, identity theft benefit, legal support, and survivor support.
Work‑life Benefits
US exempt employees: flexible time off (unlimited, managerial approval), 11 paid national holidays (not applicable in Phoenix, AZ, Puerto Rico or Redwood employees).
Phoenix, AZ, Puerto Rico & Redwood exempt/non‑exempt hourly employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays.
Additional time off may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs, and a global shutdown between Christmas and New Years.
Occupancy Structure
BMS has an occupancy structure that determines where an employee must conduct work: site‑essential, site‑by‑design, field‑based, and remote‑by‑design roles. Site‑essential roles require 100% onsite shifts. Site‑by‑design roles may be eligible for a hybrid model with at least 50% onsite. Field‑based and remote‑by‑design roles require physical travel to visit customers, patients, or partners and attend meetings as directed.
Supporting People with Disabilities
BMS is dedicated to ensuring people with disabilities can excel through a transparent recruitment process, reasonable accommodations, and ongoing support. Applicants can request accommodations before accepting a job offer. For assistance, contact adastaffingsupport@bms.com.
Candidate Rights
BMS will consider qualified applicants with arrest and conviction records, pursuant to applicable laws. If you expect to work from Los Angeles County, please see additional information at https://careers.bms.com/california-residents/.
Data Protection
We will never request payments, financial information, or social security numbers during the application or recruitment process. Learn more at https://careers.bms.com/fraud‑protection.
Contact & Additional Information
R1597891: Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development
#J-18808-Ljbffr
Position Summary
The Clinical Biomarker Asset Lead will be responsible for developing and executing translational strategies in solid tumor oncology for assigned programs. The role involves acting as a lead scientist to implement and deliver biomarker strategies for clinical programs, developing reports and publications on translational data to support asset development, and contributing to regulatory submissions. The individual will work on cross‑functional project teams to drive the execution of translational/biomarker plans with disease and lab scientists, and with BMS members from clinical, medical, commercial, regulatory, and diagnostics. The lead will also engage external academic collaborators and Key Opinion Leaders.
Key Responsibilities
Integrate translational research and clinical development, developing biomarker strategies in alignment with clinical objectives, leading data generation and interpretation, and communicating results to development teams.
Understand the external research environment and partner with internal and external functions to coordinate translational development deliverables.
Engage functional groups to develop, champion, and align biomarker strategies for development projects in support of the R&D portfolio goals.
Effectively engage with teams and matrix leadership to define, revise, and progress translational biomarker plans.
Analyze progress, apply critical thinking, and solve problems to deliver key data and interpretations essential for decision making.
Deliver high‑quality biomarker strategies for mechanism of action/resistance, target engagement, pharmacodynamics endpoints, and patient selection.
Ensure the output of biomarker plans meets established project standards.
Engage team members to align biomarker strategies with clinical operational plans and functional capabilities to execute a robust translational biomarker data package to support trial and program.
Build productive relationships with team members that interact with the translational clinical biomarker group.
Interface with functional areas to ensure strategic alignment and identify resources needed to deliver biomarker goals.
Engage external collaborators and scientific KOLs to support translational goals.
Communicate key biomarker program information, risks, and milestones, and manage information flow across team members.
Qualifications & Experience
Ph.D. in Oncology, immunology, or related field.
5–8+ years of industry experience, including 3–5 years in oncology, biomarkers, translational, or correlative research.
Previous experience as Biomarker Lead for late‑stage clinical trials; experience in phases II/III required.
Comprehensive knowledge of principles, concepts, and methodologies within drug discovery or clinical development.
Significant understanding of the role of translational research and clinical biomarkers in drug development.
Demonstrated knowledge of oncology and/or tumor‑immunology disease biology.
Regulatory submission experience in the solid tumor space highly desirable.
In‑depth understanding of solid tumor oncology and current evolving clinical landscape.
Strong scientific background with understanding of clinical, translational, and mechanistic data and a proven track record of publications.
Understanding of early or late‑stage drug and translational development process; experience implementing a biomarker strategy.
Clinical protocol authoring and regulatory document review.
Working knowledge of biomarker platforms including genomics, gene expression, immune profiling, and flow cytometry.
Excellent data analysis and problem‑solving skills.
Exceptional verbal and written communication skills with experience developing manuscripts, presentations, and regulatory submissions (INDs/NDAs).
Proven scientific/project leadership experience and global team collaboration.
Compensation Overview
Cambridge, MA: $214,020 – $259,344
Princeton, NJ: $186,110 – $225,519
Benefits
Health coverage: medical, pharmacy, dental, and vision care.
Well‑being support: BMS Well‑Being Account, BMS Living Life Better, and Employee Assistance Programs.
Financial well‑being and protection: 401(k), disability insurance, life insurance, accident insurance, supplemental health insurance, business travel protection, identity theft benefit, legal support, and survivor support.
Work‑life Benefits
US exempt employees: flexible time off (unlimited, managerial approval), 11 paid national holidays (not applicable in Phoenix, AZ, Puerto Rico or Redwood employees).
Phoenix, AZ, Puerto Rico & Redwood exempt/non‑exempt hourly employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays.
Additional time off may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs, and a global shutdown between Christmas and New Years.
Occupancy Structure
BMS has an occupancy structure that determines where an employee must conduct work: site‑essential, site‑by‑design, field‑based, and remote‑by‑design roles. Site‑essential roles require 100% onsite shifts. Site‑by‑design roles may be eligible for a hybrid model with at least 50% onsite. Field‑based and remote‑by‑design roles require physical travel to visit customers, patients, or partners and attend meetings as directed.
Supporting People with Disabilities
BMS is dedicated to ensuring people with disabilities can excel through a transparent recruitment process, reasonable accommodations, and ongoing support. Applicants can request accommodations before accepting a job offer. For assistance, contact adastaffingsupport@bms.com.
Candidate Rights
BMS will consider qualified applicants with arrest and conviction records, pursuant to applicable laws. If you expect to work from Los Angeles County, please see additional information at https://careers.bms.com/california-residents/.
Data Protection
We will never request payments, financial information, or social security numbers during the application or recruitment process. Learn more at https://careers.bms.com/fraud‑protection.
Contact & Additional Information
R1597891: Associate Director, Oncology Clinical Biomarker Asset Lead, Translational Development
#J-18808-Ljbffr